Legal & General Group’s Greenwich LifeSciences GLSI Stock Holding History

Legal & General Group’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.4K	Sell	516 -65	-11%	-$1.7K	﹤0.01%	3133
2025 Q4	$12.2K	Sell	581 -81	-12%	-$853	﹤0.01%	3190
2025 Q3	$6.59K	Hold	662	–	–	﹤0.01%	3346
2025 Q2	$6K	Hold	662	–	–	﹤0.01%	3370
2025 Q1	$6.32K	Hold	662	–	–	﹤0.01%	3247
2024 Q4	$7.43K	Hold	662	–	–	﹤0.01%	3301
2024 Q3	$9.51K	Hold	662	–	–	﹤0.01%	3284
2024 Q2	$11.4K	Buy	+662	New	+$9.67K	﹤0.01%	3267
2022 Q2	–	Sell	-427	Closed	-$8K	–	3574
2022 Q1	$8K	Hold	427	–	–	﹤0.01%	3447
2021 Q4	$10K	Hold	427	–	–	﹤0.01%	3460
2021 Q3	$17K	Hold	427	–	–	﹤0.01%	3328
2021 Q2	$19K	Buy	+427	New	+$16.1K	﹤0.01%	3308

Other funds holding GLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Legal & General Group's GLSI Position: Q1 2026 in Review

Legal & General Group reduced its Greenwich LifeSciences (GLSI) stake by 11% in Q1 2026, selling an estimated $1.7K and leaving 516 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3133.

Legal & General Group first reported a position in GLSI in Q2 2021 and has held it in 12 quarters since. The position peaked at $19K in Q2 2021. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

Legal & General Group held 516 shares of Greenwich LifeSciences worth $12.4K as of Q1 2026.
Legal & General Group sold 65 Greenwich LifeSciences shares in Q1 2026, an estimated $1.7K.
Greenwich LifeSciences made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #3133 holding.
Legal & General Group first reported a position in Greenwich LifeSciences in Q2 2021 and has held it in 12 quarters since.
Legal & General Group's Greenwich LifeSciences position peaked at $19K in Q2 2021.
64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.